| Literature DB >> 8367021 |
D H Malin1, R E Plotner, S J Radulescu, R N Ferebee, J R Lake, P G Negrete, P J Schaefer, M K Crothers, D E Moss.
Abstract
Aged (24-month-old) rats were treated chronically with methanesulfonyl fluoride (MSF), an acetylcholinesterase (AChE) inhibitor with selectivity for central nervous system AChE, or with injection vehicle alone. Twelve 0.22 mg/kg IP injections were given over 4 weeks. MSF rats showed significantly greater speed and accuracy on a 1 trial/day discriminative reward learning task. The chronic MSF treatment resulted in a 56% decrease in brain AChE activity but no discernable locomotor side effects and no liver damage as indicated by aspartate transferase activity.Entities:
Mesh:
Substances:
Year: 1993 PMID: 8367021 DOI: 10.1016/0197-4580(93)90127-w
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673